rasagiline

Generic: rasagiline

Labeler: chartwell rx, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name rasagiline
Generic Name rasagiline
Labeler chartwell rx, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

rasagiline mesylate .5 mg/1

Manufacturer
Chartwell RX, LLC

Identifiers & Regulatory

Product NDC 62135-676
Product ID 62135-676_17dd92b2-969b-16f1-e063-6394a90aee89
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA201892
Listing Expiration 2026-12-31
Marketing Start 2018-07-27

Pharmacologic Class

Classes
monoamine oxidase inhibitor [epc] monoamine oxidase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62135676
Hyphenated Format 62135-676

Supplemental Identifiers

RxCUI
608328 636664
UPC
0362135677305 0362135676308
UNII
LH8C2JI290

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rasagiline (source: ndc)
Generic Name rasagiline (source: ndc)
Application Number ANDA201892 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • .5 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (62135-676-30)
source: ndc

Packages (1)

62135-676-30 30 TABLET in 1 BOTTLE (62135-676-30)

Ingredients (1)

rasagiline mesylate (.5 mg/1)

Linked Drug Pages (1)

Rasagiline ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "17dd92b2-969b-16f1-e063-6394a90aee89", "openfda": {"upc": ["0362135677305", "0362135676308"], "unii": ["LH8C2JI290"], "rxcui": ["608328", "636664"], "spl_set_id": ["d9168d62-814a-444f-9d70-11674def339d"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (62135-676-30)", "package_ndc": "62135-676-30", "marketing_start_date": "20240501"}], "brand_name": "Rasagiline", "product_id": "62135-676_17dd92b2-969b-16f1-e063-6394a90aee89", "dosage_form": "TABLET", "pharm_class": ["Monoamine Oxidase Inhibitor [EPC]", "Monoamine Oxidase Inhibitors [MoA]"], "product_ndc": "62135-676", "generic_name": "Rasagiline", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rasagiline", "active_ingredients": [{"name": "RASAGILINE MESYLATE", "strength": ".5 mg/1"}], "application_number": "ANDA201892", "marketing_category": "ANDA", "marketing_start_date": "20180727", "listing_expiration_date": "20261231"}